All German Center for Infection Research articles
-
NewsHuman clinical study launched using phage lysin to eliminate staph in the nasal microbiome
A “first-in-human” study with the novel drug candidate HY-133 began on 10 July with the recruitment of clinically healthy volunteers who tested positive for Staphylococcus aureus colonisation of the nose.
-
NewsScientists investigate effectiveness of non-pharmaceutical interventions against pathogens
Scientists have investigated the success of non-pharmaceutical interventions, analysing almost two million SARS-CoV-2 genomes that occurred in the German population during the years of the pandemic.
-
NewsTwo ways that members of the microbiome fight salmonella infections
Researchers have identified two mechanisms through which Klebsiella bacteria combat the spread of salmonella in the gut.
-
NewsCall issued for actionable steps in response to the rising threat of antimicrobial resistance (AMR)
The AMR Multi-Stakeholder Partnership Platform has developed key recommendations for action on antimicrobial resistance for consideration by United Nations (UN) Member States in the UN General Assembly High-Level Meeting on AMR.
-
NewsCompeting bacteria yield possible alternative to antibiotics
Scientists have discovered a new so-called lantibiotic, namely epilancin A37. It is produced by staphylococci that colonize the skin and acts specifically against their main competitors there, the corynebacteria.
-
NewsAiCuris and DZIF sign Collaboration and License Option Agreement
AiCuris Anti-infective Cures AG and the German Center for Infection Research (DZIF) have announced the signing of a collaboration and license option agreement.
-
NewsTrial offers insights into treatment options for bloodstream infections
An international clinical trial has been able to gain decisive new insights into the treatment of bloodstream infections with the pathogen Staphylococcus aureus (SAB).
-
NewsNew antibiotics make TB bacterium less pathogenic for humans
Researchers have identified new, antibiotic molecules that target Mycobacterium tuberculosis and make it less pathogenic for humans.
-
NewsResearchers decode new antibiotic clovibactin
Researchers have discovered and deciphered the mode of action of a new antibiotic, clovibactin, which is derived from a soil bacterium.
-
NewsMonoclonal antibody shows promise for treating chronic hepatitis B and D infections
In a preclinical study, the potential of an engineered investigational human monoclonal antibody for the treatment of chronic hepatitis B and hepatitis D has been demonstrated.
-
NewsAchilles heel is uncovered in Helicobacter pylori
Researchers have discovered a weakness in the bacterium Helicobacter pylori, which could be exploited to develop new drugs.
-
NewsResearcher receives €1.5m from ERC to probe insecticide resistance in malaria transmission
Dr Victoria Ingham, a scientist at Heidelberg Medical Faculty and the German Center for Infection Research (DZIF), has been awarded an ERC Starting Grant of €1.5 million for her research on the infectious disease malaria.
